Alnylam Pharmaceuticals, Inc. (ALNY) Is At $82.44 Formed Wedge; 2 Analysts Covering Primo Water (PRMW)

August 7, 2017 - By Migdalia James

Among 3 analysts covering Primo Water (NASDAQ:PRMW), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Primo Water had 6 analyst reports since August 5, 2015 according to SRatingsIntel. Barrington Research downgraded the shares of PRMW in report on Friday, October 30 to “Market Perform” rating. Zacks upgraded Primo Water Corporation (NASDAQ:PRMW) rating on Wednesday, August 5. Zacks has “Hold” rating and $7.25 target. As per Tuesday, October 11, the company rating was maintained by Barrington Research. Barrington Research upgraded the shares of PRMW in report on Tuesday, December 29 to “Outperform” rating. See Primo Water Corporation (NASDAQ:PRMW) latest ratings:

03/04/2017 Broker: BMO Capital Markets Rating: Market Perform New Target: $15.00 Initiates Coverage On

Alnylam Pharmaceuticals, Inc. (ALNY) formed wedge up with $84.91 target or 3.00% above today’s $82.44 share price. Alnylam Pharmaceuticals, Inc. (ALNY) has $7.54 billion valuation. The stock increased 1.15% or $0.94 on August 4, reaching $82.44. About shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has risen 33.54% since August 7, 2016 and is uptrending. It has outperformed by 16.84% the S&P500.

Among 21 analysts covering Alnylam Pharmaceuticals (NASDAQ:ALNY), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. Alnylam Pharmaceuticals had 49 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was initiated by FBR Capital with “Outperform” on Tuesday, August 11. The firm has “Mkt Perform” rating by Leerink Swann given on Thursday, October 6. The firm has “Buy” rating given on Thursday, October 6 by Jefferies. The firm earned “Buy” rating on Monday, June 12 by Chardan Capital Markets. The rating was upgraded by JP Morgan to “Overweight” on Friday, March 11. The firm earned “Buy” rating on Monday, June 26 by Needham. The stock has “Overweight” rating by JP Morgan on Friday, August 5. Cowen & Co maintained Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on Friday, August 4 with “Buy” rating. Needham maintained Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) rating on Monday, July 10. Needham has “Buy” rating and $9800 target. The company was maintained on Friday, August 28 by JMP Securities.

Since May 15, 2017, it had 2 insider purchases, and 3 selling transactions for $17.81 million activity. On Monday, May 15 the insider Vaishnaw Akshay sold $2.84M. $21.38 million worth of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) was bought by Sanofi. Another trade for 11,500 shares valued at $751,502 was made by KEATING LAURIE on Tuesday, May 30. Another trade for 9,375 shares valued at $656,250 was made by Mason Michael on Tuesday, May 16.

Investors sentiment decreased to 0.77 in 2016 Q4. Its down 0.25, from 1.02 in 2016Q3. It turned negative, as 64 investors sold Alnylam Pharmaceuticals, Inc. shares while 65 reduced holdings. 35 funds opened positions while 64 raised stakes. 78.05 million shares or 3.80% more from 75.19 million shares in 2016Q3 were reported. Glenmede Tru Na holds 0% or 175 shares. Blackrock Management Limited Liability Corp invested in 36,732 shares. Employees Retirement Association Of Colorado has 16,792 shares. 35,063 were reported by Parametric Port Associate Limited Liability Co. Aviva Plc has invested 0.01% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Alliancebernstein Lp owns 47,805 shares or 0% of their US portfolio. Profund Ltd Liability Corp stated it has 31,480 shares. 3,879 were accumulated by Henderson Grp Inc Public Ltd. Guggenheim Capital Ltd Liability Corporation holds 79,083 shares or 0.01% of its portfolio. Advsrs Asset Management accumulated 0.01% or 22,918 shares. Oxford Asset Management holds 0.04% or 19,723 shares in its portfolio. Citadel Advisors Ltd has 9,632 shares for 0% of their portfolio. Winfield holds 15 shares. Mitsubishi Ufj Tru holds 0.02% or 290,157 shares in its portfolio. First Tru Advsr Limited Partnership stated it has 0.08% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY).

Since March 22, 2017, it had 5 buys, and 1 sale for $153,446 activity. 13,249 Primo Water Corporation (NASDAQ:PRMW) shares with value of $183,499 were sold by WARNOCK DAVID L. $10,794 worth of Primo Water Corporation (NASDAQ:PRMW) was bought by Hass David W. on Thursday, May 18. $5,600 worth of Primo Water Corporation (NASDAQ:PRMW) was bought by CASTANEDA MARK. Sheehan Matthew had bought 250 shares worth $2,741 on Wednesday, May 17.

Investors sentiment decreased to 0.98 in 2016 Q4. Its down 0.14, from 1.12 in 2016Q3. It worsened, as 11 investors sold Primo Water Corporation shares while 37 reduced holdings. 19 funds opened positions while 28 raised stakes. 15.51 million shares or 0.60% less from 15.60 million shares in 2016Q3 were reported. Geode reported 171,839 shares. Cortina Asset Llc has 432,436 shares for 0.22% of their portfolio. California Pub Employees Retirement Systems invested in 83,768 shares. Bessemer Grp Inc Inc owns 14,400 shares or 0% of their US portfolio. Navellier & Assocs holds 0.08% in Primo Water Corporation (NASDAQ:PRMW) or 40,772 shares. Vanguard Grp Incorporated Inc has 973,846 shares for 0% of their portfolio. Tiaa Cref Invest Ltd owns 0% invested in Primo Water Corporation (NASDAQ:PRMW) for 70,784 shares. Allianz Asset Mgmt Ag reported 252,448 shares stake. Ny State Common Retirement Fund holds 22,996 shares. Ontario – Canada-based Royal Bank Of Canada has invested 0% in Primo Water Corporation (NASDAQ:PRMW). 294,446 are held by Blackrock Advsr Limited Liability Com. G2 Invest Prtnrs Llc has 1% invested in Primo Water Corporation (NASDAQ:PRMW). State Street holds 0% of its portfolio in Primo Water Corporation (NASDAQ:PRMW) for 312,245 shares. New York-based Kings Point Mgmt has invested 0.12% in Primo Water Corporation (NASDAQ:PRMW). Blackrock Japan Company Ltd holds 0% or 5,329 shares.

Primo Water Corporation provides multi-gallon purified bottled water, self-service refill water and water dispensers. The company has market cap of $360.12 million. The Company’s products are sold through various retailers in the United States and Canada. It currently has negative earnings. It operates through two divisions: Primo Water (Water) and Primo Dispensers (Dispensers).

The stock increased 1.35% or $0.16 on August 4, reaching $12.05. About shares traded. Primo Water Corporation (NASDAQ:PRMW) has declined 3.15% since August 7, 2016 and is downtrending. It has underperformed by 19.85% the S&P500.